Logo image of ARC.CA

ARCPOINT INC (ARC.CA) Stock Fundamental Analysis

TSX-V:ARC - TSX Venture Exchange - CA03966D1078 - Common Stock - Currency: CAD

0.1  0 (0%)

Fundamental Rating

0

Overall ARC gets a fundamental rating of 0 out of 10. We evaluated ARC against 17 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of ARC have multiple concerns. ARC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARC had negative earnings in the past year.
ARC.CA Yearly Net Income VS EBIT VS OCF VS FCFARC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 5M -5M

1.2 Ratios

ARC has a worse Return On Assets (-132.82%) than 81.25% of its industry peers.
Industry RankSector Rank
ROA -132.82%
ROE N/A
ROIC N/A
ROA(3y)-47.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARC.CA Yearly ROA, ROE, ROICARC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 200 -200 400 600 800 1K

1.3 Margins

Looking at the Gross Margin, with a value of 32.39%, ARC is in line with its industry, outperforming 43.75% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for ARC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARC.CA Yearly Profit, Operating, Gross MarginsARC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

ARC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ARC has more shares outstanding than it did 1 year ago.
ARC has a worse debt/assets ratio than last year.
ARC.CA Yearly Shares OutstandingARC.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
ARC.CA Yearly Total Debt VS Total AssetsARC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M 15M

2.2 Solvency

ARC has an Altman-Z score of -9.40. This is a bad value and indicates that ARC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -9.40, ARC is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.4
ROIC/WACCN/A
WACC6.18%
ARC.CA Yearly LT Debt VS Equity VS FCFARC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 0.25 indicates that ARC may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.25, ARC is doing worse than 87.50% of the companies in the same industry.
A Quick Ratio of 0.24 indicates that ARC may have some problems paying its short term obligations.
With a Quick ratio value of 0.24, ARC is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.24
ARC.CA Yearly Current Assets VS Current LiabilitesARC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

ARC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.41%.
The Revenue for ARC has decreased by -38.73% in the past year. This is quite bad
EPS 1Y (TTM)6.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-38.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARC.CA Yearly Revenue VS EstimatesARC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 5M 10M 15M
ARC.CA Yearly EPS VS EstimatesARC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARC.CA Price Earnings VS Forward Price EarningsARC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARC.CA Per share dataARC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ARC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARCPOINT INC

TSX-V:ARC (2/18/2025, 7:00:00 PM)

0.1

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners15.2%
Ins Owner ChangeN/A
Market Cap11.81M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.08
BVpS-0.14
TBVpS-0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -132.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.39%
FCFM N/A
ROA(3y)-47.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.24
Altman-Z -9.4
F-ScoreN/A
WACC6.18%
ROIC/WACCN/A
Cap/Depr(3y)289.79%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-103.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-174.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3091.67%
OCF growth 3YN/A
OCF growth 5YN/A